A comparative evaluation of various methods for microalbuminuria screening

American Journal of Nephrology

Volumn 28, Issue 2, 2008, Pages 324-329

  Sarafidis, Pantelis A ^a,c   Riehle, Jessica ^a   Bogojevic, Zvezdana ^a   Basta, Emad ^a   Chugh, Atul ^b   Bakris, George L ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Diabetes; Hypertension; Kidney disease; Urinary albumin excretion

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RESPONSE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; TEST STRIP; URINALYSIS; URINARY EXCRETION;

ADULT; AGED; ALBUMINURIA; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAGENT STRIPS; REPRODUCIBILITY OF RESULTS; URINALYSIS;

EID: 38349066476     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111825     Document Type: Article

References (16)

1. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 suppl 1):S1-S266.
2. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW; American Diabetes Association: Nephropathy in diabetes. Diabetes Care 2004;27(suppl 1):S79-S83.
3. Khosla N, Sarafidis PA, Bakris GL: Microalbuminuria. Clin Lab Med 2006;26:635-653.
4. Sarafidis PA, Khosla N, Bakris GL: Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis 2007;49:12-26.
5. Lasaridis AN, Sarafidis PA: Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials? Am J Hypertens 2003;16:689-697.
6. Sarafidis PA, Bakris GL: Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant 2006;21:2366-2374.
7. Rowe DJ, Bagga H, Betts PB: Normal variations in rate of albumin excretion and albumin to creatinine ratios in overnight and daytime urine collections in non-diabetic children. Br Med J (Clin Res Ed) 1985;291:693-694.
8. Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002;13:1034-1039.
9. von Schenck H: Validation of albumin determined in urine with the HemoCue point-ofcare analyser. Scand J Clin Lab Invest 2003;63:119-126.
10. Florvall G, Basu S, Helmersson J, Larsson A: Hemocue urine albumin point-of-care test shows strong agreement with the results obtained with a large nephelometer. Diabetes Care 2006;29:422-423.
11. HemoCue AB, Ängelholm, Sweden: HemoCue Albumin 201 System. Package Insert, 2004.
12. Bayer HealthCare LLC, Elkhart, Ind., USA: CLINITEK® Microalbumin Reagent Strips for Determining Albumin and Creatinine in Urine. Package Insert, 2006.
13. http://www.roche-diagnostics.us/products_services/micral.htm (accessed March 14, 2007).
14. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
15. Jacobs DR Jr, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC: Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 2002;155:1114-1119.
16. Kidney Disease Outcomes Quality Initiative (K/DOQI): K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43(5 suppl 1):S1-S290.